Gaviscon Infant oral powder sachets

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

Sodium alginate; Magnesium alginate

Inapatikana kutoka:

Forum Health Products Ltd

INN (Jina la Kimataifa):

Sodium alginate; Magnesium alginate

Kipimo:

225mg ; 87.5mg

Dawa fomu:

Oral powder

Njia ya uendeshaji:

Oral

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 01010201; GTIN: 9300631074038 9300631074038

Tabia za bidhaa

OBJECT 1
GAVISCON INFANT
Summary of Product Characteristics Updated 16-Sep-2015 | Forum Health
Products Limited
1. Name of the medicinal product
Gaviscon Infant.
2. Qualitative and quantitative composition
Each unit dose sachet of 0.65 g powder contains 225 mg sodium alginate
and 87.5 mg magnesium
alginate.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Sachet of powder.
4. Clinical particulars
4.1 Therapeutic indications
Gaviscon Infant helps to prevent gastric regurgitation in infants
where competence of the cardiac
sphincter has not been fully established.
The indications for use are gastric regurgitation, gastro-oesophageal
reflux and reflux associated with
hiatus hernia in infants and young children.
4.2 Posology and method of administration
If symptoms persist for more than 7 days, or worsen, seek medical
advice.
POSOLOGY
For infants aged 1 to 2 years. Not to be used in premature infants or
infants under one year except under
medical supervision.
Mix immediately before use as directed below:
Infants under 4.5 kg (10lb) – one sachet should be used
Infants over 4.5kg (10lb) – two sachets should be used
Bottle fed infants:
– Mix each sachet into 115 ml (4 fl oz) of feed in the bottle.
– Shake well
– Feed as normal
Breast fed infants and other infants up to 2 years:
– Mix each sachet with 5 ml (1 teaspoon) of cooled boiled water until
a smooth paste is formed.
– Add another 10 ml (2 teaspoons) of cooled boiled water and mix
– For breast fed infants give Gaviscon Infant part way through each
feed or meal using a spoon or
feeding bottle.
– For all other infants give Gaviscon Infant at the end of each meal
using a spoon, or feeding bottle.
Treatment should not be administered more than six times in any 24
hour period.
Not suitable for children over 2 years of age, adults or the elderly.
RENAL INSUFFICIENCY: Not to be used when treating infants with known
or suspected impairment of renal
function (see section 4.3).
METHOD OF ADMINISTRATION:
For oral used after mixing with water or m